Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) insider Russ Angold sold 221,746 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $1.55, for a total transaction of $343,706.30. Following the completion of the sale, the insider now directly owns 400,678 shares in the company, valued at $621,050.90. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) traded up 3.87% during midday trading on Tuesday, hitting $1.61. 180,678 shares of the company’s stock traded hands. The company’s market capitalization is $41.27 million. Ekso Bionics Holdings, Inc. has a 52 week low of $0.99 and a 52 week high of $6.38. The company has a 50 day moving average of $1.97 and a 200-day moving average of $2.60.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Ekso Bionics Holdings, Inc. (EKSO) Insider Sells 221,746 Shares of Stock” was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2017/08/15/insider-selling-ekso-bionics-holdings-inc-ekso-insider-sells-221746-shares-of-stock.html.

A number of equities research analysts recently commented on EKSO shares. Zacks Investment Research raised shares of Ekso Bionics Holdings from a “sell” rating to a “hold” rating and set a $2.25 price objective on the stock in a research note on Tuesday, May 9th. B. Riley reissued a “buy” rating and issued a $4.00 price objective on shares of Ekso Bionics Holdings in a research note on Wednesday, May 10th.

Hedge funds have recently bought and sold shares of the company. Intellectus Partners LLC increased its stake in Ekso Bionics Holdings by 5.3% in the second quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock valued at $244,000 after buying an additional 5,294 shares during the last quarter. Independence Advisors LLC bought a new stake in Ekso Bionics Holdings during the second quarter valued at about $1,840,000. Carl Domino Inc increased its stake in Ekso Bionics Holdings by 262.4% in the first quarter. Carl Domino Inc now owns 46,966 shares of the company’s stock valued at $193,000 after buying an additional 34,008 shares during the last quarter. National Planning Corp increased its stake in Ekso Bionics Holdings by 116.2% in the second quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after buying an additional 126,000 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in Ekso Bionics Holdings by 32.9% in the second quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock valued at $1,650,000 after buying an additional 176,197 shares during the last quarter. Hedge funds and other institutional investors own 5.03% of the company’s stock.

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.